|
Clinical Data
The following clinical studies support the claims of SYSTANE® Lubricant Eye Drops. To view an available summary of an abstract, click on the hyperlinked study title.
SYSTANE® Lubricant Eye Drops
- Christensen MT, Cohen S, Rinehart J, Akers F, Pemberton B, Bloomenstein M, Lesher M, Kaplan D, Meadows D, Meuse P, Hearn C, Stein JM. Clinical evaluation of an HP-Guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 2004. Jan;28(1):55-62. Study summary information
- Przydryga J, Hartstein I, Khwarg S. Results of a community-based evaluation of a lubricant eye drop. Presented at: The 107th Annual American Optometric Association Congress; June 23-27, 2004; Orlando, FL. Presented at: the European Association for Vision and Eye Research, Joint European Research Meeting in Ophthalmology and Vision; September 24-27 2004; Vilamoura, Portugal. Pending publication in Current Medical Research and Opinion. View Poster
- Meadows DL, Ketelson HA. Physical/Chemical Characteristics of the Human Tear Film that Impacts Performance & Efficacy of Artificial Tear Products. Tear Film and Ocular Surface Society 2004.
SYSTANE® Extends Tear Film Break-up Time
- Christensen MT, Stein JM, Stone RP, Meadows DL. Evaluation of the effect on tear film break-up time extension by artificial tears in dry eye patients. Presented at: 23rd Biennial Cornea Research Conference; October 3-4, 2003; Boston, Mass.
- Ousler GW, Emory TB, Welch D, Abelson MB. Factors that influence the inter-blink interval (IBI) as measured by the ocular protection index (OPI). Presented at: The Association of Research in Vision and Ophthalmology (ARVO); 2002.
- Nally L, Ousler GW, Abelson MB. Ocular discomfort and tear film break-up time in dry eye patients: a correlation. Invest Ophthalmol Vis Sci. 2000;41(4):1436. ARVO Abstract.
- Guillon M, Chamberlain P, Marks MG, Stein JM. Effect of Eye Drop Compositional Characteristics on Tear Film. Presented at: The Association of Research in Vision and Ophthalmology (ARVO); April 25-29, 2004; Fort Lauderdale, FL.
SYSTANE® Compatibility with Restasis*
- Sall KN, Cohen SM, Christensen, MT, Stein JM. An Evaluation of the Efficacy of a Cyclosporine-Based Dry Eye Therapy when used with Marketed Artificial Tears as Supportive Therapy in Dry Eye. Eye & Contact Lens. 2006;32(1):21-26.
- RESTASIS* prescribing information.
SYSTANE® Lubricity
- Ketelson HA, Asgharian B, Chowhan M, Meadows D. In-vitro Characterization of Physical Property Attributes for Polymer Systems Used in Artificial Tear Products. Abst. ARVO 2004:No 70.
- Korb DR, Greiner JV. Et. Al. Lid-Wiper Epitheliopathy and Dry-Eye Symptoms in Contact Lens Wearers. The CLAO J. 2002: 28(4):211-216.
- Korb DR, Herman JP, Greiner JV, Scaffidi RC, Finnemore VM, Exford JM, Blackie CA, Douglass T. Lid Wiper Epitheliopathy and Dry Eye Symptoms. Eye & Contact Lens 2005; 31(1):2-8.
SYSTANE® Pre- and Post-Contact Lens Wear Improves Comfort
- Cohen S, Potter, W, Christensen MT. Use of SYSTANE to help reduce symptoms of dry eye associated with contact lens wear. Presented at: the 107th Annual American Optometric Association Congress; June 23-27, 2004; Orlando, FL.
Ocular Protection Index
- Ousler GW, Emory TB, Welch D, Abelson MB. Factors that influence the inter-blink interval (IBI) as measured by the ocular protection index (OPI). (Poster presentation) The Association of Research in Vision and Ophthalmology (ARVO), 2002.
- Nally L, Ousler GW, Abelson MB. Ocular discomfort and tear film break-up time in dry eye patients: a correlation. IOVS 2000 41;4(ARVO Abstract):1436.
Glycocalyx
- Korb DR, Craig J, Doughty M, Guillon J, Smith G, Tomlinson A. The Tear Film: Structure, Function and Clinical Examination. BCLA, 2002.
|  |
